Clinical trials in youth with type 2 diabetes

Pediatric Diabetes

Volumn 12, Issue 1, 2011, Pages 50-57

  Gemmill, Julie Anne L ^a   Brown, Rebecca J ^a   Nandagopal, Radha ^a,b   Rodriguez, Luisa M ^c   Rother, Kristina I ^a  

^a NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES   (United States)

^b EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^c TEXAS CHILDREN S HOSPITAL   (United States)

Author keywords

Adolescent; Clinical trials; Pediatric; Type 2 diabetes; Youth

Indexed keywords

EXENDIN 4; GLIBENCLAMIDE PLUS METFORMIN; GLIMEPIRIDE; INSULIN; METFORMIN;

ARTICLE; BEHAVIOR THERAPY; CLINICAL RESEARCH; CLINICAL TRIAL (TOPIC); COMPARATIVE STUDY; DRUG DOSE TITRATION; EMBASE; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; JUVENILE; MEDLINE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SYSTEMATIC REVIEW;

ADOLESCENT; CHILD; CLINICAL TRIALS AS TOPIC; DIABETES MELLITUS, TYPE 2; HUMANS; PATIENT SELECTION; RISK FACTORS;

EID: 79251507670     PISSN: 1399543X     EISSN: 13995448     Source Type: Journal    
DOI: 10.1111/j.1399-5448.2010.00657.x     Document Type: Article

References (43)

1. Dabelea D, Bell RA, D'Agostino RB, Jr. et al. Incidence of diabetes in youth in the United States. JAMA 2007: 297: 2716-2724.
2. Boyd JD, Jackson RL. Levels of control in the treatment of diabetes mellitus. JAMA 1938: 111: 906-909.
3. Jackson RL, Boyd JD, Smith TE. Stabilization of the diabetic child. Am J Dis Child 1940: 59: 332-241.
4. Zietler PS. Children and adolescents with type 2 diabetes: characteristics of the TODAY study participants at baseline. LWPES/ESPE 8th Joint meeting, New York, 2009.
5. Effect of Short-Term Beta-Cell Rest in Adolescents and Young Adults with Type 2 Diabetes Mellitus. (available from).
6. The Effect of Byetta and Symlin on Post-meal Meal Blood Sugar Levels in Children with Type 2 Diabetes (T2DM). (available from).
7. Jones KL, Arslanian S, Peterokova VA, Park JS, Tomlinson MJ. Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial. Diabetes Care 2002: 25: 89-94.
8. Gottschalk M, Danne T, Vlajnic A, Cara JF. Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study. Diabetes Care 2007: 30: 790-794.
9. Malloy J, Capparelli E, Gottschalk M, Guan X, Kothare P, Fineman M. Pharmacology and tolerability of a single dose of exenatide in adolescent patients with type 2 diabetes mellitus being treated with metformin: a randomized, placebo-controlled, single-blind, dose-escalation, crossover study. Clin Ther 2009: 31: 806-815.
10. Gellar L, Nansel TR. High and low glycemic index mixed meals and blood glucose in youth with type 2 diabetes or impaired glucose tolerance. J Pediatr 2009: 154: 455-458.
11. Sellers EA, Dean HJ. Short-term insulin therapy in adolescents with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2004: 17: 1561-1564.
12. A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in Adolescents. (available from).
13. Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents with Type 2 Diabetes. (available from).
14. Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY). (available from).
15. Safety of Liraglutide in Pediatric Patients with Type 2 Diabetes. (available from).
16. Situational Problem Solving in Adolescents with Type 2 Diabetes: Enhancing a Randomized Controlled Trial. (available from).
17. Study of Intensive, Home-Based Family Therapy to Improve Illness Management in Youth with Diabetes. (available from).
18. Personalized Exercise for Adolescents with Diabetes. (available from).
19. Partners for Better Health in Adolescent Type 2 Diabetes: The Buddy Study. NIH Study T-DK-0413. (available from).
20. Brown RJ, Walter M, Rother KI. Ingestion of diet soda before a glucose load augments glucagon-like peptide-1 secretion. Diabetes Care 2009: 32: 2184-2186.
21. A Research Study to Determine the Safety and Efficacy of Glucovance Compared to Metformin and Glyburide in Children and Adolescents with Type 2 Diabetes. (available from).
22. Gottschalk M, Danne T, Fuerst-Recktenwald S. Ethnic origin is unrelated to autoimmunity and residual pancreatic function in 471 youth with clinically diagnosed type 2 diabetes. Pediatr Diabetes 2009: 10: 240-247.
23. Shield JP, Lynn R, Wan KC, Haines L, Barrett TG. Management and 1 year outcome for UK children with type 2 diabetes. Arch Dis Child 2009: 94: 206-209.
24. Dabelea D, Mayer-Davis EJ, Lamichhane AP et al. Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care 2008: 31: 1422-1426.
25. Mayer-Davis EJ, Dabelea D, Lamichhane AP et al. Breast-feeding and type 2 diabetes in the youth of three ethnic groups: the SEARCh for diabetes in youth case-control study. Diabetes Care 2008: 31: 470-475.
26. Tfayli H, Bacha F, Gungor N, Arslanian S. Phenotypic type 2 diabetes in obese youth: insulin sensitivity and secretion in islet cell antibody-negative versus -positive patients. Diabetes 2009: 58: 738-744.
27. Saad R, Gungor N, Arslanian S. Progression from normal glucose tolerance to type 2 diabetes in a young girl: longitudinal changes in insulin sensitivity and secretion assessed by the clamp technique and surrogate estimates. Pediatr Diabetes 2005: 6: 95-99.
28. Gungor N, Bacha F, Saad R, Janosky J, Arslanian S. Youth type 2 diabetes: insulin resistance, beta-cell failure, or both? Diabetes Care 2005: 28: 638-644.
29. Gungor N, Arslanian S. Progressive beta cell failure in type 2 diabetes mellitus of youth. J Pediatr 2004: 144: 656-659.
30. Weiss R, Caprio S, Trombetta M, Taksali SE, Tamborlane WV, Bonadonna R. Beta-cell function across the spectrum of glucose tolerance in obese youth. Diabetes 2005: 54: 1735-1743.
31. Reinehr T, Schober E, Roth CL, Wiegand S, Holl R. Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers. Horm Res. 2008: 69: 107-113.
32. Tebbi CK. Treatment compliance in childhood and adolescence. Cancer 1993: 71: 3441-3449.
33. Tamaroff MH, Festa RS, Adesman AR, Walco GA. Therapeutic adherence to oral medication regimens by adolescents with cancer. II. Clinical and psychologic correlates. J Pediatr 1992: 120: 812-817.
34. Villarruel AM, Jemmott LS, Jemmott JB, Eakin BL. Recruitment and retention of Latino adolescents to a research study: lessons learned from a randomized clinical trial. J Spec Pediatr Nurs 2006: 11: 244-250.
35. Pinhas-Hamiel O, Standiford D, Hamiel D, Dolan LM, Cohen R, Zeitler PS. The type 2 family: a setting for development and treatment of adolescent type 2 diabetes mellitus. Arch Pediatr Adolesc Med 1999: 153: 1063-1067.
36. Liese AD, Liu L, Davis C et al. Participation in pediatric epidemiologic research: the SEARCH for Diabetes in Youth Study experience. Contemp Clin Trials 2008: 29: 829-836.
37. Tait AR, Voepel-Lewis T, Malviya S. Participation of children in clinical research: factors that influence a parent's decision to consent. Anesthesiology 2003: 99: 819-825.
38. Juvenile Diabetes Research Foundation International. 2008 Annual Report. 2008.
39. Pinhas-Hamiel O, Zeitler P. Acute and chronic complications of type 2 diabetes mellitus in children and adolescents. Lancet 2007: 369: 1823-1831.
40. Sellers EA, Blydt-Hansen TD, Dean HJ, Gibson IW, Birk PE, Ogborn M. Macroalbuminuria and renal pathology in First Nation youth with type 2 diabetes. Diabetes Care 2009: 32: 786-790.
41. Staffileno BA, Coke LA. Recruiting and retaining young, sedentary, hypertension-prone African American women in a physical activity intervention study. J Cardiovasc Nurs 2006: 21: 208-216.
42. Zeitler P, Epstein L, Grey M et al. Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 2007: 8: 74-87.
43. Meier JJ, Butler AE, Saisho Y et al. Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans. Diabetes 2008: 57: 1584-1594.